TrialNaunyn-Schmiedeberg's archives of pharmacology2026

Pharmacokinetics and safety of a new free-base formulation of tenofovir alafenamide 25 mg in healthy volunteers: a randomized, open-label, four-period, fully replicated crossover bioequivalence study.

Eunwoo Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.